Colorectal Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Neuropsychological Tests
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Common genetic variation and performance on standardized cognitive tests.
|
20125193 |
2010 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
The synthesis of middle-to-late-replicating DNA can be affected independently of the rest of the genome by down-regulating the tumor suppressor PREP1 (PKNOX1).
|
29453404 |
2018 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Prep1 is essential for embryogenesis, but in the adult it also acts as a tumor suppressor.
|
30604851 |
2018 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Previously we have shown that Prep1 is a haploinsufficient tumor suppressor that inhibits neoplastic transformation by competing with myeloid ecotropic integration site 1 for binding to the common heterodimeric partner Pbx1.
|
25157139 |
2014 |
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability.
|
21715654 |
2011 |
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
Immunohistochemistry on tissue micrroarrays (TMA) generated from three distinct human cohorts comprising a total of some 1000 human tumors revealed that 70% of the tumors express no or extremely low levels of Prep1, unlike normal tissues.
|
20106730 |
2010 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Pre-B-cell leukemia transcription factor regulating protein 1 (Prep1) is a homeodomain transcription factor that plays a primary role in organogenesis and metabolism.
|
31618597 |
2019 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
These data implicate the upregulated hepatic expression of Pknox1 in T2DM complicated with NAFLD may be caused by the reduced expression of miR-17 family, indicating that developing miRNA-mediated regulation strategies on Pknox1 may provide new therapeutic options for metabolic disease.
|
30338914 |
2018 |
Metabolic Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
In this review we have underlined how important metabolic functions are controlled by TALE proteins, in particular by Prep1, leading to hypothesis that its suppression might represent beneficial effect in the care of metabolic diseases.
|
30002646 |
2018 |
Metabolic Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
These data implicate the upregulated hepatic expression of Pknox1 in T2DM complicated with NAFLD may be caused by the reduced expression of miR-17 family, indicating that developing miRNA-mediated regulation strategies on Pknox1 may provide new therapeutic options for metabolic disease.
|
30338914 |
2018 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.020 |
Biomarker
|
disease |
BEFREE |
All these findings suggest that disruption of the Prep1/p160 molecular interaction enhances insulin sensitivity impaired by ceramides in skeletal muscle cells and indicate this complex as an important target for type 2 diabetes.
|
29069751 |
2017 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Pre-B-cell leukemia homeobox (Pbx)-regulating protein-1 (Prep1) is a ubiquitous homeoprotein involved in early development, genomic stability, insulin sensitivity, and hematopoiesis.
|
25157139 |
2014 |
Neoplasm Metastasis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
These findings point to a novel role of the PREP1 homeoprotein in the control of the TGF-β pathway, EMT, and metastasis in NSCLC.
|
25157139 |
2014 |
Neoplasm Metastasis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Pre-B-cell leukemia transcription factor (PBX)/three-amino-acid loop extension (TALE) class transcription factors [PBX1-4, Meis homeobox (Meis) 1-3, pbx/knotted 1 homeobox (Prep) 1, 2] are involved in tumorigenesis and metastasis.
|
21703237 |
2011 |
Down Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our results provide a rationale for the involvement of PREP1 in the apoptotic phenotype of DS tissues and indicate that differences in Prep1 level can have drastic effects.
|
20110257 |
2010 |
Teratocarcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
By using fibroblasts from DS patients and by overexpressing Prep1 in F9 teratocarcinoma and Prep1(i/i) MEF to single out the role of the protein, we report that excess Prep1 increases the sensitivity of cells to genotoxic stress and the extent of the apoptosis directly correlates with the level of Prep1.
|
20110257 |
2010 |
Complete Trisomy 21 Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our results provide a rationale for the involvement of PREP1 in the apoptotic phenotype of DS tissues and indicate that differences in Prep1 level can have drastic effects.
|
20110257 |
2010 |
Down Syndrome
|
0.020 |
AlteredExpression
|
disease |
LHGDN |
Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance.
|
12771203 |
2003 |
Down Syndrome
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance.
|
12771203 |
2003 |
Teratocarcinoma
|
0.020 |
Biomarker
|
disease |
LHGDN |
F9 teratocarcinoma cells stably transfected with PREP-1 had an increased DNA binding activity to a PREP-PBX-responsive element.
|
12871956 |
2003 |
Complete Trisomy 21 Syndrome
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance.
|
12771203 |
2003 |
Retinitis Pigmentosa
|
0.010 |
Biomarker
|
disease |
BEFREE |
Progression of retinitis pigmentosa on multimodal imaging: The PREP-1 study.
|
30552737 |
2019 |
Fatty Liver
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
MiR-17 family-mediated regulation of Pknox1 influences hepatic steatosis and insulin signaling.
|
30338914 |
2018 |
Viral myocarditis
|
0.010 |
Biomarker
|
disease |
BEFREE |
MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization.
|
29524390 |
2018 |